The raised guidance and strong enrollment trends suggest continued momentum. Monitor the CFO transition and any updates on the search for a successor, as well as the impact of new campus openings on future enrollment growth.
Price Chart
Executive Summary
Covista reported Q1 FY2027 revenue of $511.5M (up 10.7% YoY) and adjusted EPS of $2.19 (up 25.1% YoY), both above consensus estimates of $491.1M and $1.83. The company raised its full-year FY2027 revenue guidance to $2,060M-$2,095M and adjusted EPS guidance to $9.00-$9.20, while CFO Robert Phelan announced planned retirement.
Key Financial Metrics
Key Facts
- Revenue of $511.5M, up 10.7% YoY, above consensus of $491.1M
- Adjusted EPS of $2.19, up 25.1% YoY, above consensus of $1.83
- GAAP diluted EPS of $1.95, up from $1.67 YoY
- Total enrollment of 104,713, up 7.6% YoY, 13th straight quarter of growth
- Adjusted EBITDA of $131.2M, up 17.1% YoY
- Raised FY2027 revenue guidance to $2,060M-$2,095M from $2,050M-$2,090M
- Raised FY2027 adjusted EPS guidance to $9.00-$9.20 from $8.90-$9.15
- Repurchased $84M of shares in Q1
- Net leverage of 0.5x as of Sep. 30, 2026
- CFO Robert Phelan announced planned retirement; will remain until successor named
Financial Impact
Revenue beat consensus by $20.4M (4.2%); adjusted EPS beat consensus by $0.36 (19.7%)
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Chamberlain | $192.4M | +7.4% |
| Walden | $216.7M | +14.1% |
| Medical and Veterinary | $102.5M | +10.0% |
Risk Factors
- CFO retirement introduces leadership transition risk
- Walden revenue growth may moderate as prior-year comparisons become more challenging
- Capital expenditure increased to $37.6M from $16.0M YoY, pressuring free cash flow
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000730464-26-000062 |
| Document: cvsa-20261029x8k.htm | 0000730464-26-000062 |
| Document: 0000730464-26-000062-index-headers.html | 0000730464-26-000062 |
| Document: 0000730464-26-000062-index.html | 0000730464-26-000062 |
| Document: 0000730464-26-000062.txt | 0000730464-26-000062 |
| 8-K Data (Synthetic) | 0000730464-26-000062 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 3d ago | 8-K | $128.40 | awaiting T+5 | awaiting T+5 | $124.33 (−3.17%) |
Oct 14, 2026 18d ago | DEFA14A | $127.24 $131.62 | ▲ +3.44% | ▲ +4.46% | $124.33 (−2.29%) |
Oct 9, 2026 23d ago | 144 | $128.87 $128.58 | ▼ −0.23% | ▲ +1.27% | $124.33 (−3.52%) |
Oct 8, 2026 24d ago | 144 | $129.38 $126.75 | ▼ −2.03% | ▼ −0.07% | $124.33 (−3.90%) |
Oct 2, 2026 4w ago | DEFA14A | $125.39 $128.87 | ▲ +2.78% | ▲ +2.35% | $124.33 (−0.85%) |
Oct 2, 2026 4w ago | DEF 14A | $125.39 $128.87 | ▲ +2.78% | ▲ +2.35% | $124.33 (−0.85%) |
Aug 13, 2026 11w ago | Insider Cluster | $132.01 $132.35 | ▲ +0.26% | ▲ +1.63% | $124.33 (−5.82%) |
Aug 11, 2026 11w ago | Insider Cluster | $128.22 $131.93 | ▲ +2.89% | ▲ +3.34% | $124.33 (−3.03%) |
Jul 28, 2026 13w ago | 8-K | $133.60 $128.91 | ▼ −3.51% | ▼ −9.04% | $124.33 (−6.94%) |
Jul 15, 2026 15w ago | Insider Cluster | $116.22 $115.13 | ▲ +0.94% | ▼ −0.73% | $124.33 (−6.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers